Reference - Detail
| RRC ID | 52078 |
|---|---|
| Author | Ito C, Nishizuka SS, Ishida K, Uesugi N, Sugai T, Tamura G, Koeda K, Sasaki A. |
| Title | Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer. |
| Journal | J Surg Res |
| Abstract |
BACKGROUND:Although surgery and chemotherapy have extended advanced gastric cancer patient survival, some patients still experience relapse and metastasis. We postulated that PI3K pathway proteins could be prognostic biomarkers for the advanced gastric cancer patients. METHODS:A retrospective cohort of 160 advanced gastric cancer patients receiving potentially curative surgery with/without chemotherapy was investigated for PIK3CA mutation and PI3K pathway protein level in the context of overall survival and relapse-free survival. RESULTS:Thirteen patients (13 of 111, 11.7%) had PIK3CA mutations in codon 545, whereas one patient (1 of 94, 1.1%) had a mutation in PIK3CA codon 1047. PI3K pathway protein immunohistochemistry demonstrated that phosphorylated AKT positive [p-AKT (+)] patients in the surgery-only group had a good prognosis in terms of overall survival and relapse-free survival. No significant association between PIK3CA mutations and PI3K pathway protein level was seen. CONCLUSIONS:This study revealed that (1) PIK3CA hotspot mutations occurred with low frequency in gastric cancer; (2) PIK3CA hotspot mutations were not directly associated with PI3K pathway activation; and (3) p-AKT (+) may be a biomarker for better outcomes for gastric cancer patients undergoing gastrectomy regardless of the PIK3CA mutation status. |
| Volume | 212 |
| Pages | 195-204 |
| Published | 2017-5-15 |
| DOI | 10.1016/j.jss.2017.01.018 |
| PII | S0022-4804(17)30037-9 |
| PMID | 28550907 |
| MeSH | Adult Aged Biomarkers, Tumor / genetics* Biomarkers, Tumor / metabolism Chemotherapy, Adjuvant Class I Phosphatidylinositol 3-Kinases Female Gastrectomy Humans Immunohistochemistry Male Middle Aged Mutation* Phosphatidylinositol 3-Kinases / genetics Phosphatidylinositol 3-Kinases / metabolism* Prognosis Real-Time Polymerase Chain Reaction Retrospective Studies Stomach Neoplasms / genetics* Stomach Neoplasms / metabolism Stomach Neoplasms / mortality Stomach Neoplasms / therapy Survival Analysis |
| IF | 1.872 |
| Times Cited | 16 |
| Resource | |
| Human and Animal Cells | MKN1(RCB1003) |